These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19735884)

  • 41. Examining margin reduction and its impact on dose distribution for prostate cancer patients undergoing daily cone-beam computed tomography.
    Hammoud R; Patel SH; Pradhan D; Kim J; Guan H; Li S; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):265-73. PubMed ID: 18406890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate.
    Guckenberger M; Pohl F; Baier K; Meyer J; Koelbl O; Flentje M; Vordermark D
    Strahlenther Onkol; 2006 Dec; 182(12):721-6. PubMed ID: 17149579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.
    Chen L; Price RA; Wang L; Li J; Qin L; McNeeley S; Ma CM; Freedman GM; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):636-47. PubMed ID: 15380601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.
    Vargas C; Fryer A; Mahajan C; Indelicato D; Horne D; Chellini A; McKenzie C; Lawlor P; Henderson R; Li Z; Lin L; Olivier K; Keole S
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):744-51. PubMed ID: 17904306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The development and clinical use of a beam ON-LINE PET system mounted on a rotating gantry port in proton therapy.
    Nishio T; Miyatake A; Ogino T; Nakagawa K; Saijo N; Esumi H
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):277-86. PubMed ID: 20005459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A filtering approach based on Gaussian-powerlaw convolutions for local PET verification of proton radiotherapy.
    Parodi K; Bortfeld T
    Phys Med Biol; 2006 Apr; 51(8):1991-2009. PubMed ID: 16585841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility of an initial adaptive bladder volume control with ultrasonography for proton-beam irradiation for prostate cancer.
    Takamatsu S; Yamamoto K; Kawamura M; Sato Y; Asahi S; Kondou T; Tameshige Y; Maeda Y; Sasaki M; Kumano T; Gabata T
    Jpn J Radiol; 2014 Oct; 32(10):618-22. PubMed ID: 25129127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer.
    De Meerleer GO; Villeirs GM; Vakaet L; Delrue LJ; De Neve WJ
    Strahlenther Onkol; 2004 Sep; 180(9):573-81. PubMed ID: 15378188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of interfraction prostate motion using megavoltage cone beam computed tomography.
    Bylund KC; Bayouth JE; Smith MC; Hass AC; Bhatia SK; Buatti JM
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):949-56. PubMed ID: 19014783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An adaptive off-line procedure for radiotherapy of prostate cancer.
    Nuver TT; Hoogeman MS; Remeijer P; van Herk M; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1559-67. PubMed ID: 17306934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
    El-Bassiouni M; Ciernik IF; Davis JB; El-Attar I; Reiner B; Burger C; Goerres GW; Studer GM
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):286-93. PubMed ID: 17707283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjoint Monte Carlo method for prostate external photon beam treatment planning: an application to 3D patient anatomy.
    Wang B; Goldstein M; Xu XG; Sahoo N
    Phys Med Biol; 2005 Mar; 50(5):923-35. PubMed ID: 15798265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dental amalgam artifact: Adverse impact on tumor visualization and proton beam treatment planning in oral and oropharyngeal cancers.
    Richard P; Sandison G; Dang Q; Johnson B; Wong T; Parvathaneni U
    Pract Radiat Oncol; 2015; 5(6):e583-8. PubMed ID: 26419441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Have we reached proton beam therapy dosimetric limitations? - A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer.
    Ding X; Li X; Qin A; Zhou J; Yan D; Stevens C; Krauss D; Kabolizdeh P
    Acta Oncol; 2018 Mar; 57(3):435-437. PubMed ID: 28774218
    [No Abstract]   [Full Text] [Related]  

  • 57. First in situ TOF-PET study using digital photon counters for proton range verification.
    Cambraia Lopes P; Bauer J; Salomon A; Rinaldi I; Tabacchini V; Tessonnier T; Crespo P; Parodi K; Schaart DR
    Phys Med Biol; 2016 Aug; 61(16):6203-30. PubMed ID: 27476548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlations between the shifts in prompt gamma emission profiles and the changes in daily target coverage during simulated pencil beam scanning proton therapy.
    Lens E; Jagt TZ; Hoogeman MS; Schaart DR
    Phys Med Biol; 2019 Apr; 64(8):085009. PubMed ID: 30921771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer.
    Cheung J; Kudchadker RJ; Zhu XR; Lee AK; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):7135-47. PubMed ID: 21076190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement and verification of positron emitter nuclei generated at each treatment site by target nuclear fragment reactions in proton therapy.
    Miyatake A; Nishio T; Ogino T; Saijo N; Esumi H; Uesaka M
    Med Phys; 2010 Aug; 37(8):4445-55. PubMed ID: 20879603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.